Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997: From scientific evidence to practice

Preventive Medicine

Volumn 38, Issue 2, 2004, Pages 121-128

  Osseby, Guy Victor ^a   Benatru, Isabelle ^a   Sochurkova, Daniela ^a   Urbinelli, Renaud ^a   Megherbi, Salah Eddine ^a   Couvreur, Grégory ^a   Moreau, Thibault ^a   Wolf, JeanEric ^b   Giroud, Maurice ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Antithrombotic treatment; Atrial fibrillation; Community; Stroke

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; FLUINDIONE; TICLOPIDINE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HISTORY OF MEDICINE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL PRACTICE; ONSET AGE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; SMOKING; STROKE;

EID: 0346401464     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2003.09.002     Document Type: Article

References (29)

1. Petersen P., Godtfredsen J., Boysen G.et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet. 1:1989;175-179.
2. Stroke prevention in atrial fibrillation study: final results. Circulation. 84:1991;527-539.
3. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N. Engl. J. Med. 323:1990;1505-1511.
4. Connolly S.J., Laupacis A., Gent M.et al. Canadian atrial fibrillation anticoagulation (CAFA) study. J. Am. Coll. Cardiol. 18:1991;349-355.
5. Ezekowitz M.D., Bridgers S., James K.E.et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N. Engl. J. Med. 327:1992;1406-1412.
6. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet. 343:1994;687-691.
7. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet. 342:1993;1255-1262.
8. Flaker G.C., MacGowan D.J., Boechler M., Fortune G., Gage B. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am. Heart J. 137:1999;307-312.
9. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 22:1991;983-988.
10. Lemesle M., Milan C., Faivre J., Moreau Th., Giroud M., Dumas R. Incidence trends of ischemic stroke and TIA in a well-defined French population from 1985 through 1994. Stroke. 30:1999;371-377.
11. Lin H.J., Wolf P.A., Kelly-Hayos M.et al. Stroke severity in atrial fibrillation: the Framingham study. Stroke. 27:1996;1760-1764.
12. Barnett H.J.M., Eliasziw M., Meldrum H.E. Drugs and surgery in the prevention of ischemic stroke. N. Engl. J. Med. 332:1995;238-248.
13. Laupacis A., Albers G., Dalen J.et al. Antithrombotic therapy in atrial fibrillation. Chest. 108:1995;352S-359S.
14. Laupacis A., Albers G., Dunn M.et al. Antithrombotic therapy in atrial fibrillation. Chest. 102:1992;426S-433S. (suppl).
15. Recommendations on stroke prevention, diagnosis and therapy. Stroke. 20:1989;1407-1431.
16. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154:1994;1449-1457.
17. Gullov A.L., Koefoed B.G., Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation. The AFASAK 2 study. Arch. Intern. Med. 12:1999;1322-1328.
18. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: stroke prevention in atrial fibrillation III study. JAMA. 279:1998;1273-1277.
19. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann. Neurol. 42:1997;857-865.
20. Gottlieb L.K., Salem-Schatz S. Anticoagulation in atrial fibrillation. Arch. Intern. Med. 154:1994;1945-1953.
21. Hunt D., Holbrook A., Rawnsley K.et al. Atrial fibrillation: predictors of warfarin prescription. J. Gen. Intern. Med. 1996;47. [suppl].
22. Stafford R.S., Singer D.E. National patterns of warfarin use in atrial fibrillation. Arch. Intern. Med. 156:1996;2537-2541.
23. Kutner M., Nixon G., Silverstone F. Physician's attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch. Intern. Med. 151:1991;1950-1953.
24. McCrory D.C., Matchar D.B., Smasa G.et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch. Intern. Med. 155:1995;277-281.
25. Man Son Hing M., Nichol G., Lan A., Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch. Intern. Med. 159:1999;667-685.
26. Go A.S., Hylek E.M., Borowsky L.H., Philipps K.A., Selby J.V., Singer D.E. Warfarin use among ambulatory patients with non-valvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (atria) study. Ann. Intern. Med. 131:1999;927-934.
27. Deplanque D., Corea F., Arquizan C., Parnetti L., Mas J.L., Gallai V.et al. Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? Heart. 82(5):1999;563-569.
28. Bradley B.C., Perdue K.S., Tisdel K.A., Gilligan D.M. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a veterans affairs medical center. Ann. J. Cardiol. 85:2000;568-572.
29. Stafford R.S., Singer D.E. Recent national patterns of warfarin use in atrial fibrillation. Circulation. 7(97):1998;1231-1233.